HEGR Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - Hedera Group AB (publ) - Alpha Spread
H

Hedera Group AB (publ)
STO:HEGR

Watchlist Manager
Hedera Group AB (publ)
STO:HEGR
Watchlist
Price: 3.6 SEK -3.23% Market Closed
Market Cap: 53.6m SEK
Have any thoughts about
Hedera Group AB (publ)?
Write Note

Profitability Summary

Hedera Group AB (publ)'s profitability score is 50/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score
50/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Hedera Group AB (publ)

Revenue
662.2m SEK
Operating Expenses
-650.9m SEK
Operating Income
11.3m SEK
Other Expenses
-7.1m SEK
Net Income
4.2m SEK

Margins Comparison
Hedera Group AB (publ) Competitors

Country Company Market Cap Operating
Margin
Net
Margin
SE
Hedera Group AB (publ)
STO:HEGR
53.6m SEK
2%
1%
US
Cigna Corp
NYSE:CI
97.2B USD
4%
2%
US
Cigna Group
XMUN:CGN
86.9B EUR
4%
2%
US
CVS Health Corp
NYSE:CVS
77.1B USD
4%
2%
DE
Fresenius Medical Care AG
XMUN:FME
22.5B EUR
7%
3%
JP
GUPPY's Inc
TSE:5127
3.5T JPY
32%
23%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR
6%
-5%
US
Laboratory Corporation of America Holdings
NYSE:LH
18.7B USD
9%
4%
US
Quest Diagnostics Inc
NYSE:DGX
17.2B USD
14%
9%
US
DaVita Inc
NYSE:DVA
13.9B USD
15%
7%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.2B EUR
7%
3%
Country SE
Market Cap 53.6m SEK
Operating Margin
2%
Net Margin
1%
Country US
Market Cap 97.2B USD
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 86.9B EUR
Operating Margin
4%
Net Margin
2%
Country US
Market Cap 77.1B USD
Operating Margin
4%
Net Margin
2%
Country DE
Market Cap 22.5B EUR
Operating Margin
7%
Net Margin
3%
Country JP
Market Cap 3.5T JPY
Operating Margin
32%
Net Margin
23%
Country DE
Market Cap 18.9B EUR
Operating Margin
6%
Net Margin
-5%
Country US
Market Cap 18.7B USD
Operating Margin
9%
Net Margin
4%
Country US
Market Cap 17.2B USD
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 13.9B USD
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 11.2B EUR
Operating Margin
7%
Net Margin
3%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Hedera Group AB (publ) Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Hedera Group AB (publ)
STO:HEGR
53.6m SEK
4%
2%
10%
3%
US
Cigna Corp
NYSE:CI
97.2B USD
9%
2%
9%
7%
US
Cigna Group
XMUN:CGN
86.9B EUR
9%
2%
9%
7%
US
CVS Health Corp
NYSE:CVS
77.1B USD
10%
3%
8%
5%
DE
Fresenius Medical Care AG
XMUN:FME
22.5B EUR
4%
2%
5%
3%
JP
GUPPY's Inc
TSE:5127
3.5T JPY
39%
26%
53%
101%
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR
-6%
-2%
3%
1%
US
Laboratory Corporation of America Holdings
NYSE:LH
18.7B USD
5%
3%
8%
5%
US
Quest Diagnostics Inc
NYSE:DGX
17.2B USD
13%
6%
11%
8%
US
DaVita Inc
NYSE:DVA
13.9B USD
104%
5%
13%
9%
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.2B EUR
4%
2%
5%
3%
Country SE
Market Cap 53.6m SEK
ROE
4%
ROA
2%
ROCE
10%
ROIC
3%
Country US
Market Cap 97.2B USD
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 86.9B EUR
ROE
9%
ROA
2%
ROCE
9%
ROIC
7%
Country US
Market Cap 77.1B USD
ROE
10%
ROA
3%
ROCE
8%
ROIC
5%
Country DE
Market Cap 22.5B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country JP
Market Cap 3.5T JPY
ROE
39%
ROA
26%
ROCE
53%
ROIC
101%
Country DE
Market Cap 18.9B EUR
ROE
-6%
ROA
-2%
ROCE
3%
ROIC
1%
Country US
Market Cap 18.7B USD
ROE
5%
ROA
3%
ROCE
8%
ROIC
5%
Country US
Market Cap 17.2B USD
ROE
13%
ROA
6%
ROCE
11%
ROIC
8%
Country US
Market Cap 13.9B USD
ROE
104%
ROA
5%
ROCE
13%
ROIC
9%
Country DE
Market Cap 11.2B EUR
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top